Proteomics International presented its PromarkerD validation clinical study results at the American...
Managing director, Dr Richard Lipscombe Presents PromarkerD in the USA
Proteomics International continues to market PromarkerD in major global markets. Dr Richard Lipscombe presented PromarkerD to key bio-analytical sector decision makers at invitation only events in Boston (7th March), San Francisco (9th March) and San Diego (10th March), in the USA. The focus of the presentation was a case study on the benefit of biomarkers in the pharmaceutical development process.
